COVID-19 and Liver Damage
An outbreak of unknown pneumonia, caused by the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2), was reported in China at the end of December 2019. On February 11, 2020, the World Health Organization officially named SARS-CoV-2 infection COVID-19 (Coronavirus Disease 2019). The most...
Saved in:
Main Authors: | L. Yu. Ilchenko, I. G. Nikitin, I. G. Fedorov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
SINAPS LLC
2020-05-01
|
Series: | Архивъ внутренней медицины |
Subjects: | |
Online Access: | https://www.medarhive.ru/jour/article/view/1055 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of arbidol (umifenovir) in patients with COVID‐19: A systematic review and meta‐analysis
by: Behnam Amani, et al.
Published: (2021-12-01) -
Novel dangerous emergent coronavirus infection
by: T. E. Sizikova, et al.
Published: (2020-06-01) -
Hypertensive disease after moderate coronavirus infection. The results of six-month follow-up
by: D. О. Fedoseeva, et al.
Published: (2023-07-01) -
Risk factors for heart failure in patients with COVID-19
by: A. V. Svarovskaya, et al.
Published: (2023-02-01) -
Rapid Emergence and Evolution of SARS-CoV-2 Intrahost Variants among COVID-19 Patients with Prolonged Infections, Singapore
by: Yvonne C.F. Su, et al.
Published: (2025-08-01)